EndoHUCA (@EHuca) header
EndoHUCA (@EHuca) profile picture

EndoHUCA

@EHuca

Servicio de Endocrinología y Nutrición Hospital Universitario Central de Asturias

 Oviedo
endohuca.org
Joined April 2024
  • Tweets29
  • Following17
  • Followers29
7Media
Photo by EndoHUCA (@EHuca)Photo by EndoHUCA (@EHuca)Photo by EndoHUCA (@EHuca)Photo by EndoHUCA (@EHuca)Photo by EndoHUCA (@EHuca)Photo by EndoHUCA (@EHuca)Photo by EndoHUCA (@EHuca)
Buen trabajo de la ADA para la DT1 en The Pitt (Cap. 2) . Cetoacidosis en adulto hispano.
Image from EndoHUCA (@EHuca)
31
Establecendo evidencias en Nutrición. Estudio SWEET deomstrando que los edulcorantes son útiles y nada perjudiciales, nature.com/articles/s42255-0… Overall, our findings indicate that prolonged consumption of S&SEs in a healthy diet is a safe strategy for obesity management.
Effect of sweeteners and sweetness enhancers on weight management and gut microbiota composition in...

Effect of sweeteners and sweetness enhancers on weight management and gut microbiota composition in...

Nature Metabolism - The SWEET project is a multicenter, randomized, controlled trial that shows that long-term consumption of sweeteners and sweetness enhancers improves body weight control and...

nature.com
52
scsafcas
31
Publicación de nuestro estudio multicentrico español con bombas y sistemas automaticos de infusion de insulina. @HUCA_Asturias @endo_ispa @endohuca @SEDiabetes @sociedadSEEN pubmed.ncbi.nlm.nih.gov/4072…
Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve...

Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve...

Introduction: Achieving optimal glycemic control in patients with type 1 diabetes mellitus (PwT1DM) is essential to prevent complications. Continuous subcutaneous insulin infusion (CSII) systems...

pubmed.ncbi.nlm.nih.gov
3
6
446
Probando la nueva tortilla de patata que vaa a comer los pacientes del #huca.,@HUCA_Asturias @endo_ispa
Image from EndoHUCA (@EHuca)
64
Exito de la Jornada de TNE Gastroenteropancreaticos de hoy en el HUCA ,@SADENO_ @endo_ispa @ASIV_Asturias @HUCA_Asturias @GrupoGetne @NeuroendocrinoS
Image from EndoHUCA (@EHuca)
2
8
356
PubMed- onx.la/62118 Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study @HUCA_Asturias #publiHUCA @ASIV_Asturias #EndocrinologyandNutrition @FINBAsturias
Image from Biblioteca HUCA (@BibliotecaHUCA)
2
1
475
Nuevos hallazgos en la apoplejía hipofisaria desde el Grupo Colaborativo Español en el que participamos activamente en nuestro Servicio. Se han publicado dso trabajos en el JCEM bit.ly/3OUt3nB y Neurosurgery bit.ly/4iBEC0o @HUCA_Asturias @endo_ispa
2
6
445
Nuevo especialista en nuestro Servicio, EL DR. TOMÁS GONZÁLEZ VIDAL, tras obtener brillantemente una ayuda "CONTRATO RIO HORTEGA". !!Enhorabuena, Tomás!!. Contigo somos mejores. @endohuca @HUCA_Asturias @endo_ispa
Image from EndoHUCA (@EHuca)
1
1
14
938
Great success of Dr Pujante presenting in #EASD2024 an oral communication with the results of MyLife Dose study with AID systema. @endo_ispa @HUCA_Asturias @EHuca @pedropuja @EliasDelgado_ @ypsomed
Image from EndoHUCA (@EHuca)
1
3
435
Ya está disponible en el HUCA la posibilidad de realizar diagnostico molecular de riesgo de malignidad para los nódulos tiroideos  con citología indeterminada. Se ha aprobado la compra del Idylla™ ThyroidPrint que nos ayudará a evitar cirugías innecesarias de tiroides.
Image from EndoHUCA (@EHuca)
15
1
26
3,459
Nueva colaboración de nuestro Servicio en un estudio analizando la diabetes en pacientes con acromegalia Glucose metabolism outcomes after pituitary surgery in patients with acromegaly | Pituitary (springer.com) @sociedadSEEN @endo_ispa @BibliotecaHUCA @astursalud
2
2
464
Orgullosos de colaborar en un estudio multicñentrico nacionaal sobre el mejor tratamiento de los pacientes con adenomas hipofisarios secretores de GH y PRL. @endo_ispa @BibliotecaHUCA @astursalud @sociedadSEEN erc.bioscientifica.com/view/…
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

Abstract. The objective of the study was to evaluate the efficacy of second-line therapies in patients with acromegaly caused by a growth hormone (GH) and prolactin (PRL) co-secreting pituitary...

journals.bioscientifica.com
2
2
424
La Dra Ares disertando sobre la formacion de los residentes en tecnologías de la diabetes en la Jornada de Sadeno @SADENO_
Image from EndoHUCA (@EHuca)
1
3
585
Los cinco nombres que cambiaron la historia de la obesidad y abrieron una nueva era en el control de la obesidad lne.es/sociedad/opinion/2024… a través de @lanuevaespana
Los cinco nombres que cambiaron la historia de la obesidad y abrieron una nueva era en el control...

Los cinco nombres que cambiaron la historia de la obesidad y abrieron una nueva era en el control...

Apuntes sobre el calado del trabajo que ha dado el Premio 'Princesa de Asturias' de Investigación a Daniel J. Drucker, Jeffrey M. Friedman, Joel F. Habener, Jens Juul Holst y Svetlana Mojsov

lne.es
60
Nueva contribución de nuestro Servicio al tratamiento de los tumores hipofisarios en un paper multicéntrico. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs doi.org/10.1530/ERC-24-0043 @endo_ispa @HUCA_Asturias @BibliotecaHUCA @endohuca @EliasDelgado_
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

Abstract. The objective of the study was to evaluate the efficacy of second-line therapies in patients with acromegaly caused by a growth hormone (GH) and prolactin (PRL) co-secreting pituitary...

journals.bioscientifica.com
3
7
339
Comunicación al Congreso Euroepeo de Endocrinología Natural history of rathke’s cleft cysts. a retrospective analysis of a fifteen centers experience in spain | ECE2024 | 26th European Congress of Endocrinology | Endocrine Abstracts endocrine-abstracts.org/ea/0…
1
351
Effectiveness of Combined First-Line Medical Treatment in Acromegaly with Prolactin Co-secretion academic.oup.com/ejendo/arti…
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

AbstractObjective. The aim of this study is to compare the response to first-line medical treatment in treatment-naive acromegaly patients with pure growth

academic.oup.com
1
68
Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists | NEJM

Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists | NEJM

A shortage of GLP-1 receptor agonists and other drugs raises questions about how limited supplies should be allocated. A proposed framework could guide governments, professional societies, and ...

nejm.org
56
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | NEJM Nueva indicación para los ArGLP1. Como dide el otro artículo del NEJM necesitamos definir la asignación justa de estos fármacos nejm.org/doi/full/10.1056/NE… @SEDiabetes @EliasDelgado_

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | NEJM

Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No approved therapies specifically target o...

nejm.org
54
Load more